What is MOTS-C?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome itself — a rare distinction among research peptides, most of which are encoded by nuclear DNA. First described in 2015, MOTS-C has become a focal point for research into mitochondria-to-nucleus communication, AMPK pathway activation, and metabolic regulation, including insulin sensitivity, fat oxidation, and the biology of aging.
What MOTS-C Is
MOTS-C is a 16-amino acid peptide encoded in the 12S rRNA region of the mitochondrial genome — not in nuclear DNA, where the vast majority of peptides and proteins are encoded. This mitochondrial origin places MOTS-C in a small and unusual class of "mitochondrial-derived peptides" (MDPs), and its discovery opened a new line of research into how mitochondria signal to the rest of the cell.
Because MOTS-C can translocate to the nucleus under metabolic stress and influence nuclear gene expression, it is studied as a candidate mediator of mitochondria-to-nucleus retrograde signaling — a communication pathway distinct from the conventional model in which the nucleus directs mitochondrial activity.
Mechanism of Action
MOTS-C's research interest centers on its role as a regulator of cellular energy metabolism:
AMPK pathway activation: MOTS-C research has demonstrated activation of AMP-activated protein kinase (AMPK), the cell's master energy-sensing enzyme. AMPK activation shifts cellular metabolism toward energy production — promoting glucose uptake, fatty acid oxidation, and mitochondrial biogenesis, while suppressing energy-consuming anabolic processes.
Mitochondria-to-nucleus signaling: Under conditions of metabolic stress, MOTS-C has been shown to translocate from mitochondria to the nucleus, where it associates with nuclear transcription factors and influences the expression of genes involved in antioxidant response and metabolic adaptation — a process researchers refer to as retrograde signaling.
Folate cycle / one-carbon metabolism: MOTS-C research has also implicated modulation of the folate cycle and one-carbon metabolism, pathways tied to nucleotide synthesis, methylation, and redox balance — areas of ongoing investigation in metabolic and aging research.
Research Applications
Since its identification, MOTS-C has been studied across a range of metabolic and aging-related research areas:
| Research Area | Focus | Notes |
|---|---|---|
| Insulin sensitivity | Glucose uptake & regulation | Demonstrated in rodent model research via AMPK activation |
| Fat oxidation | Lipid metabolism | Downstream of AMPK pathway activation |
| Mitochondrial biogenesis | Cellular energy production | Linked to AMPK-mediated signaling |
| Aging biology | Age-related metabolic decline | Endogenous MOTS-C levels decline with age |
| Retrograde signaling | Mitochondria-to-nucleus communication | Active area of mechanistic research |
Because endogenous MOTS-C levels decline with age — paralleling broader patterns of mitochondrial dysfunction — it is frequently referenced in research exploring the mitochondrial genome as a source of biologically active signaling peptides relevant to metabolic aging.
Combination Research
MOTS-C is sometimes studied alongside other research compounds to investigate cross-pathway metabolic effects:
With GLP-1 pathway compounds: Because MOTS-C's research focus (AMPK activation, insulin sensitivity, fat oxidation via mitochondrial signaling) and GLP-1/incretin pathway compounds (appetite regulation, glucose-dependent insulin secretion) act through distinct mechanisms, researchers sometimes study the two together to characterize combined effects on glucose and lipid metabolism. For more on the GLP-1 pathway, see our What is GLP3-R? guide. Reconstitute each compound separately in its own vial — do not mix in the same vial.
With GH-axis compounds: MOTS-C's AMPK-driven metabolic effects are mechanistically distinct from GHRH analogues such as tesamorelin, which act on the pituitary GH/IGF-1 axis. Comparative research between the two approaches can help isolate mitochondrial-AMPK effects from GH-axis-mediated metabolic effects. See our What is Tesamorelin? guide for more on the GHRH pathway, or our Tesamorelin vs MOTS-C comparison for a side-by-side breakdown.
Reconstitution for Research
MOTS-C is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with Bacteriostatic Water before use in research protocols.
Standard protocol: For the 10mg vial, add 1 mL Bacteriostatic Water for a 10 mg/mL concentration. For the 40mg vial, add 4 mL Bacteriostatic Water, also yielding 10 mg/mL. The compound dissolves readily and produces a clear, colorless solution. Inject BAC Water slowly down the vial wall and swirl gently — do not shake. Refrigerate at 2-8°C after reconstitution. Stable 28-42 days.
For full reconstitution parameters and a dosing calculator that computes exact draw volumes, visit our Reconstitution Guide and Dosing Calculator.